Showing results (21-30 of 346) with videos related to
Sort By:
Pageof 35
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Haemopoietic growth factor and dose intensity in high-grade and intermediate-grade lymphomaR Pettengell, D CrowtherClinical and Experimental Immunology|March 1, 1983
Lymphocyte migration in malignant diseaseD Crowther, J WagstaffDevelopments in Biological Standardization|April 13, 1977
Effects of BCG and Corynebacterium parvum on immune reactivity in melanoma patientsN Thatcher, D CrowtherAnnals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2002
Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancerT Meyer, A E Nelstrop, M Mahmoudi, et al.Annals of Clinical Biochemistry|January 1, 1991
A review of the role of established tumour markersG H Beastall, B Cook, G J Rustin, et al.Gynecologic Oncology|April 1, 1996
Metastatic cerebral choriocarcinoma coexistent with a viable pregnancyA Dana, G J Saldanha, R Doshi, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Savings obtained by CA-125 measurements during therapy for ovarian carcinoma. The North Thames Ovary GroupG J Rustin, A Nelstrop, J Stilwell, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1991
Treatment of relapsed Hodgkin's disease using a weekly chemotherapy of short duration: results of a pilot study in 20 patientsJ A Radford, D CrowtherAnnals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Advanced ovarian cancer. Tumour markersG J Rustin, M E van der Burg, J S BerekBritish Journal of Obstetrics and Gynaecology|December 1, 1987
Cisplatin, vincristine, methotrexate and bleomycin (POMB) as initial or palliative chemotherapy for carcinoma of the cervixG J Rustin, E S Newlands, B M Southcott, et al.Pageof 35